男友太凶猛1v1高h,大地资源在线资源免费观看 ,人妻少妇精品视频二区,极度sm残忍bdsm变态

Global EditionASIA 中文雙語Fran?ais
Business
Home / Business / Companies

Genetron, JD Health team up over cancer management

By Liu Zhihua | chinadaily.com.cn | Updated: 2021-05-21 16:57
Share
Share - WeChat
Executives of JD Health celebrate during a ceremony to mark the listing of the company on the Hong Kong Stock Exchange at JD headquarters in Beijing, Dec 8, 2020. [Photo/IC]

Genetron Holdings Ltd, a precision oncology platform company in China also known as Genetron Health, announced on Thursday a strategic partnership with JD Health, a subsidiary of Chinese e-commerce giant JD, to create innovative solutions for full-cycle cancer management.

The partnership encompasses both online and offline components, and focuses on six key areas, which are consumer healthcare, digitization of liver disease management, government medical associations, sharing of customer screening resources, industry and user education, and consolidation of oncology doctors and experts on a single platform.

The first phase of the partnership will focus on liver and lung cancer, Genetron Health said in a press release.

Genetron Health will cooperate with JD Health to cover early cancer screening, molecular profiling, therapy selection and drug resistance monitoring.

In May and June, the two companies will launch a series of marketing and educational activities for people at high risk of developing liver cancer. Meanwhile, JD Health’s online network of doctors and retail pharmacies will have an option to use Genetron Health’s products to help non-small cell lung cancer patients make their therapy selection decisions.

Xin Lijun, senior vice-president of JD and CEO of JD Health, said the two companies will explore the early liver cancer screening field together to enable earlier patient treatment and improve the penetration of liver cancer screening services in the industry.

Wang Sizhen, co-founder and CEO of Genetron Health, said the partnership combines his company’s precision oncology capabilities with JD Health’s leading online healthcare platform in China, representing an innovative commercialization strategy for molecular diagnostics products in oncology.

Top
BACK TO THE TOP
English
Copyright 1995 - . All rights reserved. The content (including but not limited to text, photo, multimedia information, etc) published in this site belongs to China Daily Information Co (CDIC). Without written authorization from CDIC, such content shall not be republished or used in any form. Note: Browsers with 1024*768 or higher resolution are suggested for this site.
License for publishing multimedia online 0108263

Registration Number: 130349
FOLLOW US
CLOSE
 
主站蜘蛛池模板: 商城县| 宜阳县| 丁青县| 庄河市| 肇庆市| 黎城县| 诏安县| 贵州省| 芮城县| 磐安县| 汉寿县| 老河口市| 得荣县| 读书| 马鞍山市| 临清市| 富川| 宁波市| 黑河市| 内乡县| 文成县| 江源县| 额济纳旗| 原平市| 夹江县| 岑溪市| 东乡县| 绥棱县| 黄平县| 涪陵区| 南陵县| 云林县| 那坡县| 宜黄县| 施甸县| 洛阳市| 元谋县| 龙山县| 垦利县| 曲阳县| 息烽县|